Skip to main content

Table 1 Patients characteristics

From: Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study

Features

n

Median [25th;75th percentile] or n (%)

Epicardial adipose tissue (mL)

1253

85 [60;115]

Age (years)

1253

61 [54;67]

Sex (M, %)

1253

720 (57)

Diabetes duration (years)

1239

11 [5;18]

Hba1c (%)

1239

7.5 [6.8;8.4]

Body mass index (kg/m2)

1215

28.7 [25.8;32.6]

Obesity (≥ 30 kg/m2)

1215

505 (42)

Waist circumference (cm)

895

104 [95;113]

Hypertension

1252

795 (63)

Dyslipidemia

1242

652 (52)

Smoking exposure

1197

505 (42)

DT2 treatment

  

- OADs

1253

1078 (86)

- GLP-1

1253

304 (24)

- i-SGLT2

1253

20 (2)

- Insulin

1253

423 (34)

Macroangiopathy

1226

108 (9)

Coronary artery disease

1224

48 (4)

Cerebrovascular disease

1249

22 (2)

Peripheral arterial occlusive disease

1094

52 (5)

Peripheral neuropathy

1108

300 (27)

Retinopathy (DR) (n,%)

1253

399 (32)

â–ª No DR: 854

▪ Mild NPDR: 201

▪ Moderate NPDR: 85

▪ Proliferative DR + laser: 76

â–ª Severe NPDR: 37

CKD (GFR < 60 et/ou ACR > 3)

1240

429 (35)

Total Cholesterol (mg/dL)

1201

1.72 [1.49;2.02]

HDL-Chol (mg/dL)

1201

0.45 [0.38;0.53]

LDL-Chol (mg/dL)

1166

1.01 [0.79;1.22]

Triglycerides (mg/dL)

1204

1.22 [0.85;1.72]

ASAT (UI/L)

1192

25 [20;31]

ALAT (UI/L)

1197

25 [18;38]

Gamma GT (UI/L)

1196

31 [22;50]

Uric acid (µM)

1105

324.5 [273;383]

Troponin (ng/mL)

828

3 [3;4]

BNP (ng/L)

855

11.7 [10;27]

High sensitive CRP (mg/L)

862

2.1 [0.9;4.7]

Fibrinogen (g/L)

861

3.5 [3.0;4.0]

Coronary artery calcium score (CAC)

1247

20 [0;198]

Creatininemia (µM)

1169

70 [57.9;85]

Albuminuria (mg/L)

1211

12 [5;36]

Proteinuria (g/L)

1080

0.09 [0.07;0.15]

Creatininuria (mmol/L)

896

9.59 [5.78;14.00]

Albumin/creatinin ratio (ACR) (mg/mmol)

976

1.00 [0.53;2.82]

Protein/creatinin ratio (g/mmol)

698

0.010 [0.006;0.016]

GFR CKD epi (mL/min/1,73 m2)

1199

93 [77.9;102.6]

KFRE (%)

964

0.003 [0.001;0.020]

  1. OADs oral antidiabetic drugs; GLP-1 glucagon like peptide 1; i-SGLT2 sodium-glucose transporter 2 inhibitor; DR diabetic retinopathy; CKD chronic kidney disease; CAC Coronary artery calcium score; ACR Albumin/creatinin ratio; GFR glomerular filtration rate; CKD epi Chronic Kidney Disease Epidemiology Collaboration equation; KFRE kidney failure risk equation